Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity

Amino-bis-phosphonates (N-BPs) such as zoledronate (Zol) have been used in anticancer clinical trials due to their ability to upregulate pyrophosphate accumulation promoting antitumor Vγ9Vδ2 T cells. The butyrophilin 3A (BTN3A, CD277) family, mainly the BTN3A1 isoform, has emerged as an important st...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncoimmunology
Huvudupphovsmän: Zocchi, Maria Raffaella, Costa, Delfina, Venè, Roberta, Tosetti, Francesca, Ferrari, Nicoletta, Minghelli, Simona, Benelli, Roberto, Scabini, Stefano, Romairone, Emanuele, Catellani, Silvia, Profumo, Aldo, Poggi, Alessandro
Materialtyp: Artigo
Språk:Inglês
Publicerad: Taylor & Francis 2017
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5384426/
https://ncbi.nlm.nih.gov/pubmed/28405500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1278099
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk